M 545 (Mirtazapine 45 mg)
Pill with imprint M 545 is Beige, Round and has been identified as Mirtazapine 45 mg. It is supplied by Mylan Pharmaceuticals Inc..
Mirtazapine is used in the treatment of depression; major depressive disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 45 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 545
Mirtazapine
- Imprint
- M 545
- Strength
- 45 mg
- Color
- Beige
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Tetracyclic antidepressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
croscarmellose sodium,
FD&C Blue No. 2,
FD&C Yellow No. 6,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polydextrose,
polyethylene glycol,
corn starch,
sodium lauryl sulfate,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-3545 | Mylan Pharmaceuticals Inc. |
| 51079-0088 | UDL Laboratories Inc. |
More about mirtazapine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1534 Reviews
- Drug class: tetracyclic antidepressants
- FDA Alerts (4)
Consumer resources
- Other brands
- Remeron, Remeron SolTab
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.